ArticleBiomedicines2025

Treatment of Advanced NSCLC Patients with an Anti-Idiotypic NeuGcGM3-Based Vaccine: Immune Correlates in Long-Term Survivors.

Zaima Mazorra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.